New aspects of brain physiology

NMR in Biomedicine

Volumn 9, Issue 7, 1996, Pages 279-296

  Ross, Brian D ^a   Blüml, Stefan ^a  

^a HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ACTION POTENTIAL; ADOLESCENT; ADULT; AGED; ANIMAL; BRAIN; BRAIN LEVEL; ENERGY METABOLISM; GLIA; HUMAN; MIDDLE AGED; NERVE CELL; NERVE REGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; PRESCHOOL CHILD; RAT; REVIEW;

ACTION POTENTIALS; ADOLESCENT; ADULT; AGED; ANIMALS; BRAIN; BRAIN CHEMISTRY; CHILD, PRESCHOOL; ENERGY METABOLISM; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; NERVE REGENERATION; NEUROGLIA; NEURONS; NEUROTRANSMITTER AGENTS; RATS;

EID: 0030299067     PISSN: 09523480     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1492(199610)9:7<279::AID-NBM435>3.0.CO;2-V     Document Type: Review

References (112)

1. Dawson, M. J., Gadian, D. G. and Wilkie, D. R. Mechanical relaxation rate and metabolism studied in fatiguing muscle by phosphorus nuclear magnetic resonance. J. Physiol. (Lond.) 299, 465 (1980).
2. Balaban, R., Bottomley, P., Brown, T. R., Gadian, D., Mountford, C., Radda, G. K., Ross, B. D., Shulman, R. G., Springer, C. and Ugurbil, K., Advances in physiological chemistry by in vivo NMR. Magn. Reson. Med. 34, 289 (1995).
3. Nicholls, J. G., Martin, A. R. and Wallace, B. G. From Neuron to Brain: A Cellular and Molecular Approach to the Function of the Nervous System, 3rd edn. Sinauer, Sunderland, MA (1992).
4. Lindvall, O., Brundin, P., Widner, H., Rehncrona, S., Gustavii, B., Frackowiak, R., Leenders, K. L., Sawle, G., Rothwell, J. C., Marsden, C. D. and Björklund, A. Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247, 574 (1990).
5. Newsholme, E. A. and Leech, A. R. (Eds), Biochemistry for the Medical Sciences, p. 952. Wiley, New York (1983).
6. Warach, S. Diffusion and perfusion MRI: functional brain imaging. In R. R. Edelman, J. R. Hesselink and M. I. Ziatkin (Eds), Clinical Magnetic Resonance Imaging, p. 828. W. B. Saunders, Philadelphia, PA (1995).
7. Lorber, J. Is your brain really necessary? (cited in) Science. 210, 1232-1234 (1980).
8. Gadian, D. G. Nuclear Magnetic Resonance and its Applications to Living Systems, 2nd edn. Oxford University Press, New York (1995).
9. Lien, Y.-H. H., Shapiro, J. I. and Chan, L. Study of brain electrolytes and organic osmolytes during correction of chronic hyponatremia. J. Clin. Invest. 88, 303 (1991).
10. Bagnasco, S., Balaban, R., Fales, H. M., Yang, Y-M. and Burg, M. Predominant osmotically active organic solutes in rat and rabbit renal medullas. J. Biol. Chem. 261, 5872 (1985).
11. Ayus, J. C., Kroghapalli, R. K. and Arieff, A. I. Treatment of symptomatic hyponatremia and its relation to brain damage, a prospective study. N. Engl. J. Med. 27, 1190 (1987).
12. Lee, J. H., Arcinue, E. and Ross, B. D., Organic osmolytes in the brain of an infant with hypernatremia. N. Engl. J. Med. 331, 439 (1994).
13. Videen, J. S., Michaelis, T., Pinto, P. and Ross, B. D. Human cerebral osmolytes durign chronic hyponatremia: a proton magnetic resonance spectroscopy study. J. Clin. Invest. 95, 788 (1995).
14. Flögel, U. Willker, W., Engelmann, J., Niendorf, T. and Leibfritz, D. Adaptation of cellular metabolism in anisosmotic conditions in a glial cell line as assessed by 13C NMR spectroscopy. Dev. Neurosci. (1996) (in press).
15. Flögel, U., Niendorf, T., Serkowa, N., Brand, A., Henke, J. and Leibfritz, D., Changes in organic solutes, volume, energy state and metabolism associated with osmotic stress in a glial cell line: a multinuclear NMR study. Neurochem. Res. 20, 793 (1995).
16. Michaelis, T., Helms, G., Merboldt, K.-D., Hanicke, W., Bruhn, H. and Frahm, J. Identifiction of scyllo-inositol in proton NMR spectra of human brain in vivo. NMR Biomed. 6, 105 (1993).
17. Masuda, T., Dobson, G. P. and Veech, R. L. The Gibbs-Donnan near-equilibrium system of heart. J. Biol. Chem. 265, 20,321 (1990).
18. Kreis, R., Ernst, T. and Ross, B. D. Absolute quantitation of water and metabolites in the human brain. II. Metabolite concentrations, J. Magn. Reson. 102, 9 (1993).
19. Kreis, R., Farrow, N. A. and Ross, B. D. Diagnosis of hepatic encephalopathy by proton magnetic resonance spectroscopy. Lancet. 336, 635 (1990).
20. Danielsen, E. R., Ernst, T., Haseler, L., Bayer, S., Shelden, C. H., Pudenz, R. and Ross, B. D. Quantitative 1H MRS suggests heterogeneity of neurochemical disorder after closed head injury. Proc. 4th Soc. Magn. Reson. (1996) 306.
21. Haussinger, D., Laubenberger, J., Vom Dahl, S., Ernst, T., Bayer, S., Langer, M., Gerok, W. and Hennig, K. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hyposmolarity and hepatic encephalopathy. Gastroenterology 107, 1475 (1994).
22. Kreis, R., Ross, B. D, Farrow, N. A. and Ackerman, Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182, 19 (1992).
23. Danielsen, E. R., Ernst, T., Geissler, A., Villamil, F., Michaelis, T. and Ross, B. D. Is hepatic encephalopathy a disturbance of cerebral osmolytes? Proc. 3rd Soc. Magn. Reson. 3, 1839 (1995).
24. Shoubridge, E. A., Briggs, R. W. and Radda, G. K. NMR saturation transfer measurements of the steady state rates of creatine kinase and ATP-synthase in the rat brain. FEBS Lett. 140, 288 (1982).
25. Cadoux-Hudson, T. A., Blackledge, M. J. and Radda, G. K. Imaging of human brain creatine kinase activity in vivo. FASEB J. 3, 2660 (1989).
26. 31P saturation transfer and phosphocreatine imaging in the monkey brain. Proc. Natl Acad. Sci. USA 88, 8372 (1991).
27. Mora, B. N., Narasimhan, P. T. and Ross, B. D. 31P magnetization transfer studies in the monkey brain. Magn. Reson. Med. 26, 100 (1992).
28. Koretsky, A. P. Insights into cellular metabolism from transgenic mice. Physiol. Rev. 75, 667 (1995).
29. van Dorsten, F. A., Reese, T., Laudy, M., van Echteld, C. J. A., Nederhoff, M. G. H., Ton, J., Laterveer, F. D., Gellerich, F. N. and Nicolay, K. P-31 Magnetic resonance studies of mitochondrial creatine kinase. From in vitro to in vivo. Am. Heart Ass. Monogr. (1996) (in press).
30. van Deursen, J., Heerschap, A., Oertemans, F., Ruitenbeek, W., Jap, P., ter Laak, H. and Wieringa, B. Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity. Cell 74, 621 (1993).
31. Stockler, S., Holzbach, U., Hanefeld, F., Marquardt, I., Helms, G., Requart, M., Hanicke, R. and Frahm, J. Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediat. Res. 36, 409 (1994).
32. 31P magnetization transfer studies of creatine kinase kinetics in living rabbit brain. Magn. Reson. Med.5, 1 (1987).
33. Eleff, S. M., Barker, P. B., Blackband, S. J., Chatham, J. C., Lutz, N. W., Johns, D. R., Bryan, R. N. and Hurko, O. Phosphorus MRS of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine. Ann. Neurol. 27, 626 (1990).
34. Kreis, R., Arcinue, E., Ernst, T., Shonk, T., Flores, R. and Ross, B. D. Hypoxic encephalopathy after near-drowning studied by quantitative 1H-magnetic resonance spectroscopy. J. Clin. Invest 97, 1 (1996).
35. Bluml, S., Haseler, L. J., Danielsen, E. R. and Ross, B. D., Creatine kinase and free-energy of ATP hydrolysis in normal and diseased human brain. Proc. 4th Int. Soc. Magn. Reson. Med. 1, 467 (1996).
36. Veech, R. L., Lawson, J. W. R., Cornell, N. W. and Krebs, H. A. Cytosolic phosphorylation potential. J. Biol. Chem. 254, 6538 (1979).
37. Cornell, N., Leadbetter, M. and Veech, R. Effects of free magnesium concentration and ionic strength on equilibrium constants for the glyceraldehyde phosphate dehydrogenase and phosphoglycerate kinase reactions. J. Biol. Chem. 254, 6522 (1979).
38. Cox, D. W. G., Morris, P. G. and Bachelard, H. S. Kinetic analysis of the cerebral creatine kinase reaction under hypoxic and hypoglycemic conditions in vitro. Biochem. J. 55, 523 (1988).
39. Graham, G. D., Blamire, A. M., Rothman, D. L., Brass, L. M., Fayad, P. B., Petroff, O. A. C. and Prichard, J. W. Early temporal variation of cerebral metabolites after human stroke monitored by in vivo proton magnetic resonance spectroscopy. Proc. 11th Soc. Magn. Reson. Med. 1, 642 (1992).
40. 1H spectroscopic imaging of stroke in man: histopathology correlates of spectral changes, Proc. 10th Soc. Magn. Reson. Med. 1, 227 (1991).
41. Rosen, B. R. Dynamic functional magnetic resonance spectroscopy. Proc. 3rd Soc. Magn. Reson. 1, 390 (1995).
42. Merboldt, K.-D., Bruhn, H., Hanicke, W., Michaelis, T. and Frahm, K. Decrease of glucose in the human visual cortex during photic stimulation. Magn. Reson. Med. 25, 187 (1992).
43. Fox, P. T. and Raichle, M. E. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc. Natl Acad. Sci. USA 83, 1140 (1986).
44. Mason, G. F., Gruetter, R., Rothman, D. L., Behar, K. L., Shulman, R. G. and Novotny, E. J. Simultaneous determination of the rates of the TCA cycle, glucose utilization, alpha-ketoglutarate/glutamate exchange, and glutamine synthesis in human brain by NMR. J. Cereb. Blood Flow Metab. 15, 12 (1995).
45. 1H NMR measurement of glucose consumption in the human brain during visual stimulation. Proc. Natl Acad. Sci. USA 90, 9896 (1993).
46. Yang, X., Hyder, F. and Shulman, R. S. Activation of single whisker barrel in rat brain localized by functional magnetic resonance imaging. Proc. Natl Acad. Sci. USA (1996) (in press)
47. Jenden, D. J. The metabolism of choline. Bull. Clin. Neurosci. 55, 99 (1990).
48. Nitsch, R. M.,Blusztajn, J. K., Pittas, A. G., Slack, B. E., Growdon, J. H. and Wurtman, R. J. Evidence for a membrane defect in Alzheimer disease brain. Proc. Natl Acad. Sci. USA 89, 1671 (1992).
49. 1H and proton-decoupled-31P in vivo chemical shift imaging of human brain. Magn. Reson. Med. 32, 104 (1994).
50. 31P MRS detects elevated cerebral inositol-1-phosphate in patients with Alzheimer's disease. Proceedings, 13th Annual Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Prague, p. 232 (1996).
51. 31P MRS in Alzheimer disease. Proceedings 4th International Society of Magnetic Resonance in Medicine, New York, Vol. 1, p. 304, (1996)
52. (b) Preece, N. E., Gadian, D. G., Houseman, J. and Williams, S. R. Lithium-induced Modulation of Cerebral Inositol Phosphate Metabolism in the Rat: A Multinuclear Magnetic Resonance Study In Vivo. Lithium 3, 287-297 (1992).
53. 31P NMR Spectroscopy of Agonist-Stimulated Phospatidylinositol Metabolism in Cat Brain. Magn. Reson. Med. 4, 221-226 (1987).
54. (d) Blüml, S, Tan, J. and Ross, B. unpublished in vitro study.
55. 1H MR in the pediatric brain: a useful tool for the evaluation of metabolic diseases? Proc. 11th Soc. Magn. Reson. Medicine 2, 2012 (1992).
56. Ross, B. D. and Michaelis, T. MR spectroscopy of the brain: 'Neurospectroscopy'. In R. R. Edelman, J. R. Hesselink, & M. I. Zlatkin (Eds), Clinical Magnetic Resonance Imaging, p. 941. W. B. Saunders, Philadelphia, PA (1996).
57. Kanamori, K. and Ross, B. D. In vivo activity of glutaminase measured by 15N NMR. Biochem. J. 305, 328 (1995).
58. 15N heteronuclear multiple quantum coherence transfer NMR. Biochem. J. 311, 681 (1995).
59. Petroff, O. A. C., Rothman, D. L., Behar, K. L. and Mattson, R. H. Estimates of the rate of GABA synthesis in patients with epilepsy. Proc. 4th Int. Soc. Magn. Reson. Med. 2, 962 (1996).
60. Manor, D., Behar, K. L., Rothman, D. L., Mason, G. F., Hooten, M. and Krystal, J. Evaluation of ketamine effects on cortical tricarboxylic acid cycle rate and GABA metabolism, in rats using MR spectroscopy. Poc. 4th Int. Soc. Magn. Reson. Med. 2, 904 (1996).
61. Ross, B. D., Jacobson, S., Villamil, F., Korula, J., Kreis, R., Ernst, T.,Shonk, T. and Moats, R. A. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 193, 457 (1994).
62. Ernst, T., Ross, B. D. and Flores, R. Cerebral MRS in infant with suspected Reye's syndrome (letter). Lancet 340, 486 (1992).
63. 13C}-NMR. Proc. 12th Soc. Magn. Reson. Med. 1, 516 (1993).
64. Hassel, B. and Sonnewald, U. Glial formation of pyruvate and lactate from TCA cycle intermediates: implications for the inactivation of transmitter amino-acids? J. Neurochem. 65, 2227 (1995).
65. Michaelis, T., Merboldt, K.-D., Bruhn, H., Hänicke, W. and Frahm, J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 187, 219 (1993).
66. Ernst, T., Kreis, R. and Ross, B. D. Absolute quantitation of water and metabolites in the human brain. Part I: compartments and water. J. Magn. Reson. 102, 1 (1993).
67. Prost, R. W., Li, S. J., Mark, L. P. and Erickson, S. E. Direct detection of gluamate/glutamine in vivo Proc. Soc. Magn. Reson. 1, 307 (1994).
68. Pan, J. W., Mason, G. F., Pohost, G. M. and Heatherington, H. P. Observation of human brain glutamate by water suppressed J-refocussed coherence transfer. Magn. Reson. Med. (1996) (in press).
69. 1H spectroscopy of major brain metabolites. Magn. Reson. Med. 21, 82 (1991).
70. 13C]glucose. J. Neurochem. 63, 1377 (1994).
71. Badar-Goffer, R. S., Ben-Yoseph, O., Bachelard, H. S. and Morris, P. G. neuronal-glial metabolism under depolarizing conditions. Biochem. J. 282, 225 (1992).
72. Balazs, R. and Haslam, R. J. Exchange transamination and the metabolism of glutamate in brain. Biochem. J. 94, 131 (1965).
73. Mason, G. F., Rothman, D. L., Behar, K. L. and Shulman, R. (1992) NMR determination of the TCA cycle rate and alpha-ketoglutarate/glutamate exchange rate in rat brain. J. Cereb. Blood Flow Metab. 12, 434-447.
74. 15N NMR. J. Biol. Chem. 270, 24,805-24,809 (1995).
75. 15N NMR studies of rat brain. In H. Bachelard (Eds.), Advances in Neurochemistry. Plenum, New York. (1996).
76. 13C-edited NMR spectroscopy. J. Cereb. Blood Flow Metab. 10, 170 (1990).
77. 13C]glutamate turnover in human brain. Proc. Natl Acad. Sci. USA 89, 9603 (1992).
78. Butterworth, R. F., Girard, G. and Giguere, J.-F. Regional differences in the capacity for ammonia removal by brain following portacaval anastomosis. J. Neurochem. 51, 486 (1988).
79. Bachelard, H. and Badar-Goffer, R. NMR spectroscopy in neurochemistry. J. Neurochem. 61, 412 (1993).
80. 13C NMR. Proceedings of the 3rd Society of Magnetic Resonance, Nice, p. 1783 (1995).
81. Nicholls, J. G., Martin, A. R. and Wallace B. G. Principles of synaptic transmission, in From Neuron to Brain: A Cellular and Molecular Approach to the Function of the Nervous System, 3rd edn, p. 184. Sinauer, Sunderland, MA (1992).
82. Ito, M. The Cerebellum and Neural Control. Raven, New York (1984).
83. Sherrington, C. S. The Brain and Its Mechanism. Cambridge University Press, London (1933).
84. Kuffler, S. W. and Yoshikami, D. The distribution of acetylcholine sensitivity at the post-synaptic membrane of vertebrate skeletal twitch muscles: ionophoretic mapping in the micron range. J. Physiol. 251, 703 (1975).
85. Katz, B. and Miledi, R. The statistical nature of the acetylcholine potential and its moleular components. J. Physiol. 244, 665 (1972).
86. Heuser, J. E., Reese, T. S., Dennis, M. J., Jan, Y., Jan, L., and Evans, L., Synaptic vesicle exocytosis captured by quick freezing and correlated with quantal transmitter release. J. Cell Biol. 81, 275 (1979).
87. Fan, P., Lavoie, J., Le, N. L. O., Szerb, J. C., and Butterworth, R. F. Neurochemical and electrophysiological studies on the inhibitory effect of ammonium ions on synaptic transmission in slices of rat hippocampus: evidence for a postsynaptic action. Neuroscience. 37, 327 (1990).
88. 13C NMR spectroscopy study of cerebral metabolism in the hyperammonemic rat, Proceedings, 4th International Society of Magnetic Resonance in Medicine, 99 (1996).
89. 1H NMR Soc Magn Reson Med. 2, 986 (1990).
90. De Stefano, N., Matthews, P. M. and Arnold, D., Reversible decreases in N-acetylaspartate after acute brain injury. Mag. Reson. Med. 34, 721-727 (1995).
91. Vion-Dury, J., Nicoli, F., Salvan, A.-M., Confort-Gouny, S., Dhiver, C., and Cozzone, P. J., Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy. Lancet 345 (8941), 60 (1995).
92. Kreis, R., Arcinue, E., Ernst, T., Shonk, T., Flores, R., and Ross, B.D., Hypoxic encephalopathy after near-drowning studied by quantitative 1H-magnetic resonance spectroscopy. J. Clin. Invest. 97, 1 (1996).
93. Volpe, J. J. (Ed). Neurology of the Newborn. Saunders, Philadelphia, pp. 33 (1987).
94. Brand, A., and Leibfritz, D., C-13, H-1 and P-31 NMR studies on a neuronal cell line, 10th annual meeting of the Society of Magnetic Resonance in Medicine, 1, 419 (1991).
95. Kamada, K., Houkin, K., Hida, K., Matsuzawa, H., Iwasaki, Y., Abe, H. and Nakada, T., Localized proton spectroscopy of focal brain pathology in humans: Significant effects of edema on spin-spin relaxation time. Magn. Reson. Med. 31 (5), 537 (1994).
96. 1H NMR spectroscopy in Canavan's disease: a report of two cases. Magn. Reson. Med. 19, 439 (1991).
97. Barker, P. B., Bryan, R. N., Kumar, A. J., and Naidu, S., Proton NMR spectroscopy of Canavan's disease. Neuropediatrics. in press (1991).
98. Grodd, W., Krageloh-Mann, I., Petersen, D., Trefz, F. K., and Harzer, K., In vivo assessment of N-acetylaspartate in brain in spongy degeneration (Canavan's disease) by proton spectroscopy. Lancet 336, 437 (1990).
99. 1H magnetic resonance spectroscopy in Canavan's disease: A case report. Ann Neurol. 30, 106 (1991).
100. Taylor, D. L., Davies, S. E. C., Obrenovitch, T. P., Doheny, M. H., Patsalos, P. N., Clark, J. B., and Symon, L., Investigation into the role of N-acetylaspartate in cerebral osmoregulation. J. Neurochem. 65, 275 (1995).
101. Ross, B. D., Ernst, T., and Kreis, R. Proton magnetic resonance spectroscopy in hypoxic ischemic disorders. In E. N. Faerber (Ed.), CNS Magnetic Resonance Imaging in Infants and Children. Mac Keith Press, London, pp. 279 (1995).
102. Hossmann, K.-A. Viability thresholds and the penumbra of focal ischemia. Ann. Neurol. 36, 557-565 (1994).
103. Gyngell, M. L., Busch, E., Schmitz, B., Kohno, K., Back, T., Hoehn-Berlage, M., and Hossman, K-A., NMR in Biomed. 8, 206-214 (1995). Evolution of acute focal cerebral ischemia in rats observed by localized 1H MRS, diffusion weighted MRI and electrophysiological monitoring.
104. Moseley, M. E., Cohen, Y., Mintorovitch, J., Chileuitt, L., Shimizu, H., Kucharczyk, J., Wendland, M. F. and Weinstein, P. R. Early Detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn. Reson. Med. 14, 330 (1990).
105. 1H MRS. Magn. Reson. Med. (1997) (in press).
106. 1H-NMR analysis of the neurochemical changes in the cerebral cortex and CSF of hydrocephalic rats and the effect of shunt treatment. Proc. 3rd Soc. Magn. Reson. 3, 1794 (1995).
107. Chumas, P. D., Drake, J. M., Del Bigio, M. R., Da Silva, M. and Tuor, U. I. Anaerobic glycolysis preceding white matter destruction in experimental neonatal hydrocephalus. J. Neurosurg. 80, 491 (1994).
108. Blüml, S., McComb, J. G. and Ross, B. D. Rapid diagnosis of hydrocephalus (Hc) in infants and children using 1H MRS and brain water determination. Proc. 4th Int. Soc. Magn. Reson. Med. 2. 1008 (1996).
109. Ross, B. D. New aspects of brain physiology (plenary lecture). Proceedings of the 4th Meeting of the International Society of Magnetic Resonance in Medicine, New York (1996).
110. Frahm, J., Kruger, G., Merboldt, K.-D. and Kleinschmidt, A. Dynamic uncoupling and recoupling of perfusion and oxidative metabolism during focal brain activation. Magn. Reson. Med 35, 143-148 (1996).
111. Bachelard, H., Badar-Goffer, R., Ben-Yoseph, O., Morris, P., Taylor, A. and Thatcher, N. 13C-MRS studies on cerebral metabolism MAGMA 2, 285-289 (1994).
112. Frahm, J. and Hanefeld, F. Localized Proton Magnetic Resonance Spectroscopy of Brain Disorders in Childhood in Magnetic Resonance Imaging and Spectroscopy in Neurochemistry (Bachelard, H. S. Ed.), in: Advances in Neurochemistry (Agranoff, B. and Suzuki, K. Eds.), Plenum, New York, in press (1997).